WAYNE, Pa.–(BUSINESS WIRE)–Synergy Biomedical, LLC, a developer of innovative biomaterials products, today announced the launch of BIOSPHERE® FLEX SP EXTREMITIES, Bioactive synthetic bone graft. Using Synergy’s proprietary BIOSPHERE® Technology, BIOSPHERE® FLEX SP Extremities is a sheet filler composed of innovative spherical bioactive glass granules combined with a porous collagen/sodium hyaluronate carrier. This product addition builds on the already very successful Synergy FLEX Sheet Putty product portfolio. Flex SP Extremities expects to be an integral solution in the upper and lower extremity market.
BIOSPHERE® FLEX SP EXTREMITIES is a third generation bioactive glass bone grafting solution. Specially developed to maximize the bone healing potential of bioactive glass. Using the well-known and reliable 45S5 bioactive glass composition which has proven to be an effective bone graft material. FLEX SP EXTREMITIES is an easy-to-handle, flexible and moldable (once hydrated) sheet putty to facilitate surgical placement. Designed to accommodate bone marrow aspiration and is available in small and medium sizes.
“The launch of BIOSPHERE® FLEX SP EXTREMITIES, the bioactive synthetic bone graft is a major step forward for our company in the extremities market,” said CEO Kevin Booth. “From the beginning, Synergy’s approach has been to clearly understand the fundamental science key to maximizing bone healing, and then to develop innovative biomaterial products. Choosing the right bone graft can be one of the most crucial decisions for upper and lower extremity applications and FLEX SP EXTREMITIES will give surgeons confidence in this decision due to the clinical success of BIOSPHERE® Technology.”
BIOSPHERE® FLEX SP EXTREMITIES uses patented bioactive glass spheres that have been shown in vivo to lead to faster and stronger bone formation. The product provides surgeons with a moldable bone graft material (when hydrated) that has one of the highest bioactive glass contents on the market.
About Synergy Biomedical, LLC
Founded in 2011, Synergy Biomedical is a privately held medical device company focused on bringing innovative and positively disruptive biomaterial-based products to the orthopedic and spine markets. The BIOSPHERE of the company® The technology represents a unique approach to advancing bone grafting technology and improving bone healing and patient outcomes.